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Most research on hepatitis B virus (HBV) infection in the United
States is limited to Asian populations, despite an equally high pre-
valence among African immigrants. The purpose of this study was
to determine testing and detection rates of HBV infection among
African-born people residing in the Chicago metropolitan area.
Methods
A hepatitis education and prevention program was developed in
collaboration with academic, clinical, and community partners for
immigrant  and refugee populations  at  risk  for  HBV infection.
Community health workers implemented chain referral sampling,
a novel strategy for recruiting hard-to-reach participants, targeting
African-born participants. Participants were tested in both clinical
and nonclinical settings. To assess infection status, blood samples
were obtained for hepatitis B surface antigen (HBsAg), core anti-
body, and surface antibody testing. Demographic information was
collected on age, sex, health insurance status, country of origin,
and years residing in the United States. Participants were notified
of testing results, and HBsAg-positive participants were referred
for follow-up medical care.
Results
Of 1,000 African-born people who received education, 445 (45%)
agreed to participate in HBV screening. There were 386 (87%)
participants tested in clinical and 59 (13%) tested in nonclinical
sites. Compared with participants who were tested in clinical set-
tings, participants tested in nonclinical settings were older, were
less likely to have health insurance, and had lived in the United
States longer (P < .005 for each). Of these, most were from the
Democratic Republic of the Congo (14%), Nigeria (13%), Ghana
(11%), Somalia (11%), or Ethiopia (10%). There were 35 (8%)
HBsAg-positive people, 37% had evidence of past infection, and
29% were immune.
Conclusions
Chain  referral  sampling  identified  many  at-risk  African-born
people with chronic HBV infection. The large proportion of HB-
sAg-positive people in this sample reinforces the need for health
promotion  programs  that  are  culturally  appropriate  and  com-
munity-driven.
Introduction
Infection with hepatitis B virus (HBV) is life threatening and may
lead to acute and chronic liver diseases (1) including cancer and
cirrhosis (2). Approximately 248 million people are estimated to
be infected worldwide (3,4), and 686,000 annual deaths are associ-
ated with the disease and its complications (5). The highest bur-
den is in Asian and African countries (6). Foreign-born Africans
are a fast-growing immigrant group in the United States. During
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the past 3 decades, migration has increased from 200,000 to 1.7
million (7,8). According to the 2010 Census, the Chicago metro-
politan area is home to approximately 50,000 African-born people,
which is more than double the number counted in the 2000 Census
(9).
Foreign-born people who enter the United States as refugees are
granted asylum and undergo a comprehensive health assessment
that includes screening for immunity to HBV infection. The med-
ical evaluation of immigrants applying for permanent residency
varies and does not incorporate testing for chronic HBV infection
(10). An estimated 54,000 people with chronic HBV infection im-
migrate to the United States annually (8).
The health status of African-born people remains largely unex-
amined. Public health reports have focused on infectious diseases,
including HIV and tuberculosis, and some studies have compared
African immigrants with African Americans (11). As African-born
people continue to migrate to the United States from diverse coun-
tries, surveillance of a broad range of chronic diseases and infec-
tions will be important, and health care practices will need to be
aligned accordingly. An estimated 29% of people with chronic
HBV infection in the United States are African-born (12). A cross-
sectional chart review of African immigrants attending an urban
clinic in Minnesota indicated that 14% had evidence of HBV in-
fection (13). The prevalence of HBV infection among African im-
migrants in Europe is similarly high (14,15).
Most research on HBV infection in the United States is limited to
Asian populations,  despite  an  equally  high prevalence  among
African immigrants (8). Little is known about the prevalence of
chronic HBV infection among African-born people residing in the
Chicago area. Improving the identification and public health man-
agement of immigrants with HBV infection is crucial to eliminat-
ing transmission and reducing the incidence of HBV-related liver
diseases (16). The aims of this study were to use a novel strategy
of chain referral sampling to conduct HBV testing and describe
the  prevalence  of  chronic  HBV infection  among  a  sample  of
people born in Africa and now residing in the Chicago metropolit-
an area.
Methods
African-born community members were recruited to participate in
the screening program through informational flyers and posters
displayed at  well-attended venues,  including temples,  grocery
stores, and restaurants, and by word-of-mouth invitation. Parti-
cipants received education on HBV infection and were offered
hepatitis B virus testing at one of several community-based health
clinics.
Procedures
Enrollment into the program occurred in 3 waves. We first enlis-
ted clientele from community-based agencies, including church
groups, federally qualified health care clinics, and a refugee clinic
affiliated with a multihospital health care organization. African-
born adults were then selected through chain-referral sampling, an
approach that has been used extensively in observational research
to recruit otherwise hard-to-reach individuals (17). The method re-
lies on natural social networks and integrates a series of parti-
cipant-informed referrals into “chain links” so that the resulting
sample closely resembles the population of interest. Finally, parti-
cipants who attended the educational sessions on hepatitis B were
offered complimentary testing for HBV infection, which included
hepatitis B surface antigen (HBsAg) as well as hepatitis B surface
antibody (anti-HBs), total hepatitis B core antibody (anti-HBc), or
both.
Test results were categorized according to the following defini-
tions: chronic infection (HBsAg+, anti-HBc+, anti-HBs−), past in-
fection (HBsAg−, anti-HBc+, anti-HBs+ or −), immune (HBsAg−,
anti-HBc−,  anti-HBs+),  and susceptible  (HBsAg−, anti-HBc−,
anti-HBs−). Specimens were sent to Quest Laboratories for test-
ing. Participants who tested negative for HBV infection received
language-concordant notification letters. Participants with posit-
ive test results were notified via telephone and a letter; they were
provided post-test counseling and were referred to a health clinic
or community-based organization. Community health workers as-
sisted participants in making appointments with local health care
providers. Immune participants were informed that no further fol-
low-up was required. People identified as being susceptible to
HBV infection received counseling and were offered hepatitis B
vaccination. The screenings were performed in clinical and non-
clinical settings from December 2012 through December 2014.
The clinic settings included community and federally qualified
health  centers,  charitable  organizations,  solo  and small  group
physician practices, and local hospitals. Physicians briefly edu-
cated participants about hepatitis B and offered a free blood test.
Consent for the blood draws was obtained from participants, and
demographic and risk factor data were collected. Results of the
screenings were provided directly to participants.
Nonclinical settings consisted of health fairs and other events hos-
ted by community and faith-based organizations. Screenings fol-
lowed educational workshops delivered in the target languages of
participants or interpreted by trained bilingual community health
workers. Community health workers assisted participants with the
consent forms, and volunteer nurses and phlebotomists performed
the blood draws.
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Data analysis
All data were analyzed using SPSS version 21 (IBM Corporation).
Participants were characterized demographically on the basis of
sex, race, age, health insurance status, years living in the United
States, country of birth, type of setting in which they were seen,
and HBV infection status. Differences between the clinical and
nonclinical settings were evaluated using the χ2 test, and signific-
ance was set at P < .05. The University of Chicago Medicine’s in-
stitutional review board approved the study protocol.
Results
Approximately 3,000 Asian- or African-born immigrants with lim-
ited English skills received education on HBV infection. Of those,
1,000 were African, and 445 (45%) African-born participants un-
derwent HBsAg testing in several health and community-based
clinics (Table 1). Most participants were black (93%), median age
was 33 years, and most were residents of the United States for less
than 10 years (71%). The proportion of uninsured participants in
nonclinical settings was significantly higher than the proportion in
clinical settings (54% vs 13%; P = .005). Participants tested in
nonclinical settings were older than those tested in clinical set-
tings (P < .001), and most had resided in the United States for
more than 10 years, whereas most of those tested in clinical set-
tings had lived in the United States for fewer than 10 years (P <
.001) (Table 1).
Thirty-five (8%) of 445 participants receiving HBV screening
were HBsAg positive. Of 194 with complete serological data for
all 3 tests, 72 (37%) had evidence of past infection, 57 (29%) were
immune, and 50 (26%) were susceptible. There were 231 parti-
cipants who had only HBsAg results available; 60 (13.5%) parti-
cipants received at least 1 dose of hepatitis B vaccine. Participants
were from 33 African countries, with the largest proportions from
Democratic Republic of the Congo (14%), Nigeria (13%), Ghana
(11%), Somalia (11%), and Ethiopia (10%). HBsAg and anti-HBc
testing results by country of origin are shown in Table 2.
Discussion
Results from this study demonstrate the utility of chain referral
sampling to engage African-born people in educational programs
and screenings for HBV infection. We tested 45% of the target
population and identified 8% with chronic HBV infection.
The strategy leveraged community health workers, in conjunction
with peer and faith-based leaders, who were in the position to en-
gage a hard-to-reach population. Community health workers are
instrumental in engaging underserved populations (18). They have
effectively intervened with populations experiencing chronic con-
ditions such as diabetes and HIV (19,20) and have assisted in im-
plementing culturally tailored programs to reduce health disparit-
ies in ethnically diverse populations (21). We reached a popula-
tion who needed services but were limited by access and language
barriers. Chain referral sampling helped to overcome some chal-
lenges of limited English language comprehension, illiteracy, and
mistrust. Our reach included nearly 20% of people with no insur-
ance and many recent immigrants with fewer than 10 years of res-
idency in the United States. Additionally, the strategy led to iden-
tification of people susceptible to HBV infection and facilitated
hepatitis B vaccination. Building on the links that the community-
based organizations and their  clientele comprised,  the referral
chains lengthened and the sampling pool widened as interest in the
program broadened to a point at which community members them-
selves became engaged and even recruited others to participate.
Establishing visibility in African immigrant communities and gen-
erating interest in future workshop cycles further lengthened the
social network links.
Similar success with an HBV testing program among immigrant
populations was identified in Europe using a similar community-
based approach (22). Stornaiuolo et al (23) examined the impact of
proactive participant recruitment in an Italian community that was
home to 5 million immigrants.  They used the mobile unit  of a
health and family counseling center dedicated to providing HIV
screenings of hard-to-reach participants and compared the results
to those obtained in their outpatient health clinic alone. The num-
ber of HIV positive people identified over a 6-year period was sig-
nificantly higher using the mobile unit than without it. Similar to
our study, intervention directly in the community led to screening
and detection rates that we assert are difficult to achieve through
clinic-based practice alone.
There  were  many lessons  learned when using a  chain  referral
sampling strategy to test African-born people for HBV infection.
Factors such as lack of health insurance, limited English profi-
ciency, ineligibility for public assistance programs, cost of health
services, lack of medical interpretation services, and the absence
of legal documentation commonly are barriers to obtaining health
care services (24). In this study, reluctance to self-identify as a re-
cent immigrant due to fear of reprisal probably compounded the
utilization challenges as well as the stigma associated with the dis-
ease. The recruitment strategy helped to mitigate this distrust be-
cause of  the natural  social  networks that  contextualized parti-
cipants’ involvement. Recommendation for HBV testing by re-
spected fellow members of the community promoted buy-in. Some
community-based organizations may have experienced communic-
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ation challenges when assisting participants with low literacy even
when the explanations of the HBV testing protocol and demo-
graphic  questionnaires  were  translated  into  their  spoken  lan-
guages. Future studies should standardize recruitment processes at
screening events and the role of community health workers, partic-
ularly those with linguistic and cultural competence.
There are at least 3 limitations to this study. First, the large pro-
portion of missing data may have led to misclassification of HBV
infection status. Second, it was not possible to screen the entire
population for HBV infection and follow-up with people found to
be infected, both of which are necessary for reducing disease pre-
valence. Cultural barriers including denial and social stigma, as
well as concerns about the cost of treatment if tested positive, ten-
ded to perpetuate racial/ethnic disparities in hepatitis B disease
despite the involvement of peers. Third, we were unable to assess
linkage to care for people who tested HBsAg positive. Strategies
that increase linkage to care for African-born people that test HB-
sAg positive are needed.
Despite these limitations, we were able to use the chain referral
strategy to implement HBV testing and identify many African-
born people with chronic HBV infection. The results indicate that
there is a need for health promotion programs that are culturally
appropriate and community-driven. Although the US Department
of Health and Human Services has made substantial efforts to im-
prove hepatitis B surveillance practices, including Centers for Dis-
ease Control and Prevention–led initiatives to systematically gath-
er  HBV-related health  information on racial/ethnic  minorities
(25,26), this article highlights the need to develop HBV-related
education,  screening,  and linkage-to-care strategies that  target
African-born people.
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Tables
Table 1. Demographic Characteristics and Testing Results of African-Born Persons Recruited Through a Chain Referral Sampling Strategy, Chicago Metropolitan
Area, 2012–2014
Variable Number (%) (N = 445)
Clinical Screening Location (%) (N =
386)
Nonclinical Screening Location (%) (N =
59) P Value
Sex
Male 219 (49) 186 (48) 33 (56)
.33
Female 226 (51) 200 (52) 26 (44)
Race
Black 411 (93) 353 (91) 58 (98)
<.004
White 11 (2) 11 (3) 0
Other 12 (3) 11 (3) 1 (2)
Not indicated 11 (2) 11 (3) 0
Age, y
<18 90 (20) 90 (23) 0
<.001
18–39 190 (43) 174 (45) 16 (27)
40–64 156 (35) 115 (30) 41 (70)
≥65 9 (2) 7 (2) 2 (3)
Health insurance status
Yes 354 (80) 330 (86) 24 (41)
.005No 83 (19) 51 (13) 32 (54)
Unknown 8 (2) 5 (1) 3 (5)
Residency in United States, y
<10 310 (70) 300 (78) 10 (17)
<.001
10–19 29 (6) 0 29 (49)
20–29 14 (3) 0 14 (24)
Unknown 92 (21) 86 (22) 6 (10)
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Table 2. Proportion of Hepatitis B Surface Antigen and Potential Exposure Based on Hepatitis B Core Antibody Positivity Among African-Born Persons by Country of
Origin, Chicago Metropolitan Area, 2012–2014
Country of Origin
HBsAg and Anti-HBc Results
HBsAg Positive, No. (%) Anti-HBc Positivea, No. (%) Total No. Tested
Algeria 0 0 2
Benin 0 0 1
Cameroon 0 0 4
Central Africa Republic 3 (43) 0 7
Chad 0 0 6
Democratic Republic of the Congo 3 (5) 21 (11) 62
Cote d’Ivoire (Ivory Coast) 1 (33) 2 (1) 3
Djibouti 2 (50) 0 4
Egypt 0 2 (1) 3
Eritrea 0 0 6
Ethiopia 2 (4.5) 2 (1) 44
Ghana 4 (8) 1 (.05) 49
Guinea 0 0 1
Kenya 0 6 (3) 11
Liberia 1 (33) 0 3
Libyan Arab Jamah 0 2 (1) 4
Malawi 0 0 2
Mauritania 0 1 (.05) 2
Morocco 0 0 4
Mozambique 0 0 3
Namibia 0 1 (.05) 5
Niger 0 0 2
Nigeria 4 (7) 4 (2) 58
Rwanda 1 (4) 1 (.05) 26
Sierra Leone 1 (50) 1 (.05) 2
Somalia 7 (15) 13 (7) 47
Sudan 5 (25) 4 (2) 20
Syria 0 0 2
Tanzania 0 1 (.05) 2
Togo 0 1 (.05) 8
Uganda 0 6 (3) 13
Zaire 1 (3) 0 34
Zimbabwe 0 0 2
Other Africab 0 3 (1.5) 3
Totals 35 (8) 72 (37) 445
Abbreviations: anti-HBc, hepatitis B core antibody; anti-HBs, hepatitis B surface antibody; HBsAG, hepatitis B surface antigen.
a 194 participants had serological data for all 3 tests (HBsAg, anti-HBc, anti-HBs).
b Three participants indicated “Africa” rather than a specific country.
PREVENTING CHRONIC DISEASE VOLUME 13, E118
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY SEPTEMBER 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2016/16_0162.htm • Centers for Disease Control and Prevention       7
